
SNZZF
Healthcare · Medical Devices · $46.3M market cap
$0.23520.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | After the close | — | — | — |
| Aug 26, 2021 | After the close | 0.00 | -0.04 | — |
| May 5, 2021 | After the close | 0.00 | -0.04 | — |
| Feb 25, 2021 | After the close | 0.00 | -0.03 | — |
| Nov 6, 2020 | Before the open | 0.00 | -0.03 | — |
| Aug 20, 2020 | After the close | 0.00 | -0.02 | — |
| May 7, 2020 | After the close | 0.00 | -0.02 | — |
| Feb 13, 2020 | After the close | -1.59 | -0.18 | +88.7% |
| Nov 7, 2019 | After the close | 0.00 | -0.15 | — |
| Aug 21, 2019 | After the close | 0.00 | -0.17 | — |
| May 8, 2019 | Before the open | — | -0.18 | — |
| Feb 14, 2019 | After the close | 0.00 | -0.02 | — |
| Nov 7, 2018 | After the close | 0.00 | -0.03 | — |
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to…
| After the close |
| 0.00 |
| -0.01 |
| — |
| May 8, 2018 | Before the open | 0.00 | -0.01 | — |
| Feb 15, 2018 | After the close | 0.00 | -0.01 | — |